17D Stock Overview Produces and markets plant-based food and beverage products in the United States. More details
Rewards Risk Analysis + 1 more risk
See All Risk Checks Capture your thoughts, links and company narrative
Add noteArcadia Biosciences, Inc. Competitors Price History & Performance
Summary of share price highs, lows and changes for Arcadia Biosciences Historical stock prices Current Share Price US$5.85 52 Week High US$7.40 52 Week Low US$1.75 Beta 1.17 1 Month Change 141.74% 3 Month Change 128.52% 1 Year Change 116.67% 3 Year Change -84.27% 5 Year Change -97.34% Change since IPO -99.90%
Recent News & Updates
Third quarter 2024 earnings released: US$0.87 loss per share (vs US$1.83 loss in 3Q 2023) Nov 14
Arcadia Biosciences, Inc. to Report Q3, 2024 Results on Nov 12, 2024 Oct 29
Second quarter 2024 earnings released: EPS: US$1.36 (vs US$0.61 in 2Q 2023) Aug 15
Arcadia Biosciences, Inc. to Report Q2, 2024 Results on Aug 13, 2024 Jul 31 Arcadia Biosciences, Inc. Announces Appointment of Mark Kawakami, as Chief Financial Officer
Arcadia Biosciences, Inc., Annual General Meeting, Jun 25, 2024 May 19 See more updates
Third quarter 2024 earnings released: US$0.87 loss per share (vs US$1.83 loss in 3Q 2023) Nov 14
Arcadia Biosciences, Inc. to Report Q3, 2024 Results on Nov 12, 2024 Oct 29
Second quarter 2024 earnings released: EPS: US$1.36 (vs US$0.61 in 2Q 2023) Aug 15
Arcadia Biosciences, Inc. to Report Q2, 2024 Results on Aug 13, 2024 Jul 31 Arcadia Biosciences, Inc. Announces Appointment of Mark Kawakami, as Chief Financial Officer
Arcadia Biosciences, Inc., Annual General Meeting, Jun 25, 2024 May 19
New major risk - Revenue and earnings growth May 10
First quarter 2024 earnings released: US$1.78 loss per share (vs US$10.86 loss in 1Q 2023) May 10
Arcadia Biosciences, Inc. to Report Q1, 2024 Results on May 09, 2024 Apr 27
New major risk - Shareholder dilution Apr 01
Full year 2023 earnings released: US$10.64 loss per share (vs US$25.65 loss in FY 2022) Mar 30
Arcadia Biosciences, Inc. to Report Q4, 2023 Results on Mar 28, 2024 Mar 15
Insufficient new directors Mar 01
Arcadia Biosciences, Inc. (Rkda) Expands Goodwheat™ Mac & Cheese with Nationwide Availability Feb 21
Arcadia Biosciences, Inc. Announces the Resignation of Laura Pitlik as Chief Marketing Officer Feb 17
Third quarter 2023 earnings released: US$1.83 loss per share (vs US$4.67 loss in 3Q 2022) Nov 12
Arcadia Biosciences, Inc. to Report Q3, 2023 Results on Nov 09, 2023 Oct 27
Second quarter 2023 earnings released: EPS: US$0.61 (vs US$6.81 loss in 2Q 2022) Aug 13
Arcadia Biosciences, Inc. to Report Q2, 2023 Results on Aug 10, 2023 Jul 23
Arcadia Biosciences, Inc. Launches Goodwheat into the Breakfast Category with New Better-For-You Pancake & Waffle Mixes and Single-Serve Quikcakes Jul 18
First quarter 2023 earnings released: US$10.86 loss per share (vs US$8.09 loss in 1Q 2022) May 16
Full year 2022 earnings released: US$25.65 loss per share (vs US$27.56 loss in FY 2021) Apr 02
Arcadia Biosciences, Inc. Announces CFO Changes Dec 01
Third quarter 2022 earnings released: US$0.12 loss per share (vs US$0.098 loss in 3Q 2021) Nov 16
Third quarter 2022 earnings released: US$0.12 loss per share (vs US$0.098 loss in 3Q 2021) Nov 12
Arcadia Biosciences, Inc. to Report Q3, 2022 Results on Nov 10, 2022 Oct 29
Arcadia Biosciences, Inc. to Report Q3, 2022 Results on Nov 10, 2022 Oct 28
Arcadia Biosciences Receives Non-Compliance Letter from Nasdaq Sep 28
Second quarter 2022 earnings released: US$0.17 loss per share (vs US$0.24 loss in 2Q 2021) Aug 13
Arcadia Biosciences, Inc. to Report Q2, 2022 Results on Aug 11, 2022 Jul 29
First quarter 2022 earnings released: US$0.20 loss per share (vs US$0.11 profit in 1Q 2021) May 14
Arcadia Biosciences, Inc. to Report Q1, 2022 Results on May 12, 2022 May 06
Arcadia Biosciences, Inc., Annual General Meeting, Jun 01, 2022 Apr 20
Full year 2021 earnings released: US$0.69 loss per share (vs US$0.47 loss in FY 2020) Apr 01
Investor sentiment improved over the past week Mar 23
Investor sentiment improved over the past week Mar 05
Arcadia Biosciences, Inc. Announces Executive Changes Feb 03
Investor sentiment improved over the past week Jan 05
Chief Growth Officer Chris Cuvelier has left the company Dec 01
Investor sentiment deteriorated over the past week Nov 23
Third quarter 2021 earnings released: US$0.098 loss per share (vs US$0.60 loss in 3Q 2020) Nov 17
Second quarter 2021 earnings released: US$0.24 loss per share (vs US$1.04 loss in 2Q 2020) Aug 18
Arcadia Biosciences, Inc. (NasdaqCM:RKDA) acquired Assets of Lief Holdings, LLC and Live Zola, LLC. from Lief Holdings, LLC and Live Zola, LLC for $6.1 million. May 18
Full year 2020 earnings released: US$0.47 loss per share (vs US$4.53 loss in FY 2019) Apr 02
Arcadia Biosciences, Inc. Expands GoodWheat™ Patent Portfolio Mar 05
Arcadia Biosciences Welcomes Debbie Carosella to Board Of Directors Feb 25
New 90-day high: €3.06 Feb 10
Arcadia Biosciences, Inc. announced that it expects to receive $25.146633 million in funding Jan 26
Arcadia Biosciences, Inc. has completed a Follow-on Equity Offering in the amount of $7.672668 million. Dec 23
New 90-day low: €2.02 Dec 22
Arcadia Biosciences, Inc. Signs Hemp Distribution Agreement with Tritium 3H, Inc Nov 25
Third quarter 2020 earnings released: US$0.60 loss per share Nov 19
Revenue misses expectations Nov 19
Revenue misses expectations Nov 13
Third quarter 2020 earnings released: US$0.60 loss per share Nov 13
Bioceres Crop Solutions Corp. (AMEX:BIOX) acquired remaining 50% interest in Verdeca LLC from Arcadia Biosciences, Inc. (NasdaqCM:RKDA) for $28 million. Nov 13
Three Farm Daughters™ Launches New Product Portfolio Powered by GoodWheat™ Nov 11
Arcadia Biosciences, Inc. to Report Q3, 2020 Results on Nov 12, 2020 Nov 07
New 90-day low: €2.30 Sep 24
Arcadia Biosciences, Inc. (NasdaqCM:RKDA) completed the acquisition of Commercial and Genetic Assets of Industrial Seed Innovations from Industrial Seed Innovations. Sep 02
New 90-day low - €2.62 Aug 25
First half earnings released Aug 14
New 90-day low - €3.06 Jul 24 Shareholder Returns 17D DE Food DE Market 7D -0.8% -4.5% -2.6% 1Y 116.7% -13.7% 6.9%
See full shareholder returns
Return vs Market: 17D exceeded the German Market which returned 6.9% over the past year.
Price Volatility Is 17D's price volatile compared to industry and market? 17D volatility 17D Average Weekly Movement 58.4% Food Industry Average Movement 3.7% Market Average Movement 4.8% 10% most volatile stocks in DE Market 11.2% 10% least volatile stocks in DE Market 2.4%
Stable Share Price: 17D's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 17D's weekly volatility has increased from 31% to 58% over the past year.
About the Company Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.
Show more Arcadia Biosciences, Inc. Fundamentals Summary How do Arcadia Biosciences's earnings and revenue compare to its market cap? 17D fundamental statistics Market cap €8.31m Earnings (TTM ) -€8.21m Revenue (TTM ) €5.25m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 17D income statement (TTM ) Revenue US$5.48m Cost of Revenue US$4.37m Gross Profit US$1.11m Other Expenses US$9.68m Earnings -US$8.57m
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) -6.28 Gross Margin 20.32% Net Profit Margin -156.29% Debt/Equity Ratio 0%
How did 17D perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/22 01:14 End of Day Share Price 2024/12/20 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Arcadia Biosciences, Inc. is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Raghuram Selvaraju H.C. Wainwright & Co. Benjamin Klieve Lake Street Capital Markets, LLC Jon Ritzenthaler Piper Sandler Companies
Show 1 more analysts